Navigation Links
Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates

The replenishment of missing neurons in the brain as a treatment for Parkinson disease reached the stage of human trials over 15 years ago, however the field is still in its infancy. Researchers from Kyoto University have now shown that dopamine-producing neurons (DA neurons) generated from monkey embryonic stem cells and transplanted into areas of the brain where these neurons have degenerated in a monkey model of Parkinson disease, can reverse parkinsonism. Their results appear in the January 3 issue of the Journal of Clinical Investigation.

Studies of animal models of Parkinson disease as well as clinical investigations, have shown that transplantation of fetal DA neurons can relieve the symptoms this disease. However the technical and ethical difficulties in obtaining sufficient and appropriate donor fetal brain tissue have limited the application of this therapy. These researchers previously demonstrated that mouse embryonic stem cells can differentiate into neurons when cultured under specific conditions. These same culture conditions, technically simple and efficient, were recently applied to primate embryonic stem cells and resulted in the generation of large numbers of DA neurons. In their current JCI study, Jun Takahashi and colleagues generated neurons from monkey embryonic stem cells and exposed these cells to FGF20, a growth factor that is produced exclusively in the area of the brain affected by Parkinson disease and is reported to have a protective effect on DA neurons. The authors observed increased DA neuron development and subsequently transplanted these neurons into monkeys treated with an agent called MPTP, which is considered a primate model for Parkinson disease. These transplanted cells were able to function as DA neurons and diminished Parkinsonian symptoms. In an accompanying commentary, J. William Langston from the Parkinson's Institute, California, describes this study as a milestone in the development of stem cell technology but ca utions that while the observations are encouraging, the reported number of surviving DA neurons was very low, only 1?% of the cells surviving, well below the estimated number of DA neurons that survive after fetal cell transplants (approximately 10%). While this may be a difference observed between transplantation in monkeys and humans, Langston stresses that it may be necessary for far more DA neurons to survive and for that survival to be long lasting in order to render this approach as a useful therapy in humans. Langston highlights that "clearly the study reported here will advance research aimed at validating the use of stem cells to treat neurodegenerative disease" and this is most welcome particularly as investigators face yet another presidential moratorium endeavoring to limit the number of human stem cell lines that can be used for future research and treatment.
'"/>

Source:ScienceDaily


Related biology news :

1. Circles Of DNA Might Help Predict Success Of Stem Cell Transplantation
2. Single-donor Islet Transplantation Procedure Shows Promise For Patients With Type 1 Diabetes
3. A New Species of Monkey is Discovered in Tanzania: The First in Africa for More Than 20 Years
4. Monkeypox mystery: New research may explain why 2003 outbreak in the US wasnt deadly
5. Shifty-eyed Monkeys Offer Window Into Brains Social Reflexes
6. Monkeying around to improve organ transplantation
7. Monkeys understand numbers across senses
8. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
9. Embryonic Stem Cells Treated With Growth Factor Reverse Hemophilia In Mice: UNC Researchers
10. Embryonic stem cells accrue genetic changes
11. Embryonic selection of sex avoids conceiving blind children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 08, 2019 , ... ... are announcing a collaboration with the National Research Council of Canada (NRC) ... knowledge in nanofabrication and lab-on-a-chip technologies and in manufacturing, LIFT will offer ...
(Date:10/8/2019)... ... October 07, 2019 , ... The future of medicine in the 21st century ... people living longer, healthier lives. But it will be up to each individual to ... MD, PhD, Chief Strategy Officer and Co-Founder of the Institute for Systems Biology and ...
(Date:10/3/2019)... ... October 01, 2019 , ... The ... chemicals, reagents, and medias and to be a more environmentally sustainable evolution to ... of years of experience and feedback from the original version we launched in ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... , ... October 03, 2019 , ... Yesterday, at the ... Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important design factors ... an attendee audience including both developers and suppliers of clinical trials, in his ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... company, has completed training and site qualification for clinical trial sites and physician ... and screening of potential clinical trial participants. , Clinical trial sites are currently ...
(Date:9/17/2019)... ... ... Tucker, a Labrador retriever, was just a puppy when he began to ... on his right hip and elbow. At one year of age, Tucker was diagnosed ... vet had seen.” He was prescribed pain medications, both oral and injectable, as well ...
(Date:9/17/2019)... ... 16, 2019 , ... MyBioGate Global Healthcare Innovation Competition Boston ... Boston, a forum organized by MyBioGate, Inc. and CUBIO Innovation Center that promotes ... process of evaluation, twelve companies out of over 200 applications were selected to ...
Breaking Biology Technology: